Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19, Aging, and Cardiometabolic Risk Factors (CARAMEL) Study: Integrating Aging, Cardiovascular, Metabolic, and Immunological Studies to Unravel COVID-19 Pathophysiology

NCT04802044 is registered in ClinicalTrials.gov with Indonesia University as lead sponsor.

NCT NCT04802044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04802044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19, Aging, and Cardiometabolic Risk Factors (CARAMEL) Study: Integrating Aging, Cardiovascular, Metabolic, and Immunological Studies to Unravel COVID-19 Pathophysiology
Lead sponsor
Indonesia University
Phase
Observational
Overall status
Unknown status
Start date
December 8, 2020
Completion date
December 31, 2023
Enrollment
440 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

aging, cardiometabolic syndrome, covid19, diabetes mellitus, immune system disorder, obesity